Throughout this medical market research, the publisher analyzed 84+ Anesthesia, Respiratory and Sleep Management companies in Europe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this report suite report contains all of the EU15 Anesthesia, Respiratory and Sleep Management market analysis, each of the market segments is also available as a stand-alone a report, MedCore.
Anesthesia Monitors Market | Europe | 2021-2027 | MedCore
Anesthesia Delivery Unit (ADU) Devices Market | Europe | 2021-2027 | MedCore
Anesthesia Disposables Market | Europe | 2021-2027 | MedCore
Ventilator Market | Europe | 2021-2027 | MedCore
Nebulizer Market | Europe | 2021-2027 | MedCore
Oxygen Therapy Market | Europe | 2021-2027 | MedCore
Therapeutic Obstructive Sleep Apnea Device Market | Europe | 2021-2027 | MedCore
Sleep Diagnostic Devices Market | Europe | 2021-2027 | MedCore
Europe Anesthesia, Respiratory and Sleep Management Market Insights
Overall, the European market for anesthesia, respiratory and sleep management devices was valued at nearly €1.9 billion in 2020 and will decline slightly over the forecast period, due to the declining ASPs and market corrections post-COVID offsetting growth in unit sales, to €1.8 billion in 2027.
The ARS market demographic includes surgery patients and senior citizens. With the decline in global air quality, illnesses of the respiratory tract, such as chronic obstructive pulmonary disease (COPD), will increase in incidence. This growth will also affect the ARS market. As the awareness and the frequency of diagnoses, as well as self-diagnoses, increases, so will the population of individuals requiring some form of treatment from this market. In the short term, however, the market was negatively impacted by COVID-19 due to mass cancellations and postponements of surgeries across all countries.
In 2020, ResMed was the leading competitor in the anesthesia, respiratory and sleep management device market. The company led the therapeutic obstructive sleep apnea device market in Europe, with a notable presence in both the sleep therapy interface and PAP device segments. This segment is so large that it positioned ResMed as the overall market leader.